Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares
Clinical trial NCT05496465 · COMPLETED
Trial details
- NCT number
- NCT05496465
- Sponsor
- ARS Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-28
- Primary completion
- 2024-02-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.